Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial

BACKGROUND: Cutaneous leishmaniasis (CL) is treated with parenteral drugs for decades with decreasing rate cures. Miltefosine is an oral medication with anti-leishmania activity and may increase the cure rates and improve compliance. METHODOLOGY/PRINCIPAL FINDINGS: This study is a randomized, open-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Paulo R., Ampuero, Julia, Guimarães, Luiz H., Villasboas, Leonardo, Rocha, Ana T., Schriefer, Albert, Sousa, Rosana S., Talhari, Anette, Penna, Gerson, Carvalho, Edgar M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006132/
https://www.ncbi.nlm.nih.gov/pubmed/21200420
http://dx.doi.org/10.1371/journal.pntd.0000912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006132/
https://www.ncbi.nlm.nih.gov/pubmed/21200420
http://dx.doi.org/10.1371/journal.pntd.0000912

Ejemplares similares